Addressing this important scientific issue urgently calls for carefully designed prospective studies that monitor Aβ/tau changes, neurodegenerative indicators, and cognitive performance over an extended period to better understand the spatial and temporal connection between hemodialysis and the pathological development of AD. Here, MAPT is linked to Alzheimer disease.